Quoin Pharmaceuticals (QNRX) Competitors $0.24 -0.04 (-15.16%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$0.25 +0.01 (+2.56%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNRX vs. CHEK, NUWE, AMIX, SINT, CTCX, NAOV, HSCS, TNON, GCTK, and BBLGShould you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include Check-Cap (CHEK), Nuwellis (NUWE), Autonomix Medical (AMIX), Sintx Technologies (SINT), Carmell (CTCX), NanoVibronix (NAOV), Heart Test Laboratories (HSCS), Tenon Medical (TNON), GlucoTrack (GCTK), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry. Quoin Pharmaceuticals vs. Check-Cap Nuwellis Autonomix Medical Sintx Technologies Carmell NanoVibronix Heart Test Laboratories Tenon Medical GlucoTrack Bone Biologics Check-Cap (NASDAQ:CHEK) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Do institutionals and insiders believe in CHEK or QNRX? 1.1% of Check-Cap shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 0.5% of Check-Cap shares are held by company insiders. Comparatively, 3.7% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor CHEK or QNRX? Check-Cap received 365 more outperform votes than Quoin Pharmaceuticals when rated by MarketBeat users. Likewise, 61.46% of users gave Check-Cap an outperform vote while only 55.56% of users gave Quoin Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCheck-CapOutperform Votes37061.46% Underperform Votes23238.54% Quoin PharmaceuticalsOutperform Votes555.56% Underperform Votes444.44% Which has higher earnings and valuation, CHEK or QNRX? Check-Cap is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.26Quoin PharmaceuticalsN/AN/A-$8.69M-$2.32-0.10 Which has more volatility & risk, CHEK or QNRX? Check-Cap has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, Quoin Pharmaceuticals has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Is CHEK or QNRX more profitable? Check-Cap's return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A Quoin Pharmaceuticals N/A -125.60%-64.77% Does the media prefer CHEK or QNRX? In the previous week, Check-Cap and Check-Cap both had 3 articles in the media. Check-Cap's average media sentiment score of 0.96 beat Quoin Pharmaceuticals' score of 0.77 indicating that Check-Cap is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQuoin Pharmaceuticals beats Check-Cap on 6 of the 11 factors compared between the two stocks. Remove Ads Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNRX vs. The Competition Export to ExcelMetricQuoin PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22M$6.90B$5.63B$7.84BDividend YieldN/A2.75%5.33%4.01%P/E Ratio-0.067.2623.5518.73Price / SalesN/A218.61388.1990.75Price / CashN/A65.6738.1734.64Price / Book0.046.386.894.23Net Income-$8.69M$142.34M$3.20B$247.47M7 Day Performance-19.40%-5.15%-3.06%-2.29%1 Month Performance-22.18%-7.55%1.51%-5.81%1 Year Performance-74.55%-11.06%9.35%-0.94% Quoin Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNRXQuoin Pharmaceuticals0.9501 of 5 stars$0.24-15.2%N/A-74.5%$1.22MN/A-0.064Short Interest ↓CHEKCheck-Cap1.0632 of 5 stars$0.91+3.0%N/A-74.6%$5.30MN/A-0.3080Analyst ForecastShort Interest ↓NUWENuwellis3.6082 of 5 stars$1.14+0.9%$17.00+1,391.2%-92.2%$4.99M$8.74M-0.0170Short Interest ↓AMIXAutonomix Medical3.5646 of 5 stars$2.03+2.0%$28.00+1,279.3%-97.0%$4.90MN/A-0.161Short Interest ↓Gap UpSINTSintx Technologies1.134 of 5 stars$2.89-3.7%N/A-72.0%$4.03M$1.25M-0.0640Short Interest ↓Gap DownCTCXCarmell1.1079 of 5 stars$0.18-4.1%N/A-95.2%$3.81M$32,839.000.0014Gap DownNAOVNanoVibronix0.95 of 5 stars$4.25-3.2%N/A-61.9%$3.37M$3.29M-3.4620Short Interest ↓Gap DownHSCSHeart Test Laboratories2.9797 of 5 stars$2.96+1.7%$13.00+339.2%-75.6%$3.20M$14,700.00-0.3710TNONTenon Medical1.5942 of 5 stars$0.98-2.2%$5.50+462.3%+160.0%$3.07M$3.32M-0.048Short Interest ↑High Trading VolumeGCTKGlucoTrack1.8858 of 5 stars$0.27-9.5%N/A-99.4%$2.81MN/A0.005Short Interest ↓Gap DownHigh Trading VolumeBBLGBone Biologics1.2037 of 5 stars$0.85-3.4%N/A-61.5%$2.78MN/A0.002Short Interest ↓Gap Up Remove Ads Related Companies and Tools Related Companies CHEK Competitors NUWE Competitors AMIX Competitors SINT Competitors CTCX Competitors NAOV Competitors HSCS Competitors TNON Competitors GCTK Competitors BBLG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNRX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QNRX Stock Free QNRX Stock Alerts